SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, both dates inclusive (the “Class Period”). Captioned Lerner v. Organon & Co., No. 25-cv-12983 (D.N.J.), the Organon class action lawsuit charges Organon and certain of Organon’s top executives with violations of the Securities Exchang ...

SAN DIEGO, July 9, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, inclusive (the "Class Period"). Captioned Lerner v. Organon & Co., No. 25-cv-12983 (D.N.J.), the Organon class action lawsuit charges Organon and certain of Organon's top executives with violations of the Securities Exchange Act of 1934. A ...

Organon (OGN) reported $1.51 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 6.7%. EPS of $1.02 for the same period compares to $1.22 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.52 billion, representing a surprise of -0.73%. The company delivered an EPS surprise of +14.61%, with the consensus EPS estimate being $0.89.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...

Organon First Quarter 2025 Earnings Disclaimer statement Cautionary Note Regarding Forward-Looking Statements Except for historical information, this presentation includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, but not limited to, statements about management's expectations about Organon's future financial performance and prospects, including expectations regarding regulatory approvals (including t ...

Organon (OGN) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Company Participants Jennifer Halchak - VP, IRKevin Ali - CEOMatthew Walsh - CFOMichael Nedelcovych - Director - Equity ResearchUmer Raffat - Senior Managing DirectorJuan Camilo Ferreira - Executive VP, Head of Research & Development and Chief Medical Officer Conference Call Participants David Amsellem - Sr. Research AnalystEthan Brown - Equity Research AnalystBhavin Patel - Analyst Operator Hello, and welcome to the Organon First Quarter twenty t ...

Organon (OGN) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Speaker0 Hello, and welcome to the Organon First Quarter twenty twenty five Earnings Call and Webcast. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. I would now like to turn the conference over to Jennifer Halczek, Vice President, Investor Relations. You may begin. Speaker1 Thank you, operator, and good morning, everyone. Thank you for joining Organon's ...

Wall Street analysts expect Organon (OGN) to post quarterly earnings of $0.92 per share in its upcoming report, which indicates a year-over-year decline of 24.6%. Revenues are expected to be $1.54 billion, down 4.9% from the year-ago quarter. Over the last 30 days, there has been a downward revision of 1.7% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe. ...

Organon & Co. (NYSE:OGN) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Juan Camilo Arjona Ferreira - Head of R&D Matt Walsh - CFO Conference Call Participants Terence Flynn - Morgan Stanley Michael Nedelcovych - TD Cowen Ethan Brown - JPMorgan David Amsellem - Piper Sandler Balaji Prasad - Barclays Jason Gerberry - Bank of America Umer Raffat - Evercore ISI Operator Thank you for standing by. My name is Celine and I will be your ...